We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Jeffrey Allen MD

Jeffrey A. Allen MD

Associate Professor, Department of Neurology, Division of Neuromuscular Medicine, University of Minnesota, Minneapolis, Minnesota

Jeffrey Allen is an Associate Professor in the Department of Neurology at the University of Minnesota, Minneapolis, MN and adjunct faculty at Northwestern University, Chicago, IL. He completed his neurology residency training at Tufts University, and neuromuscular fellowship at Harvard. Dr. Allen’s research has focused on defining the clinical and diagnostic boundaries of the inflammatory neuropathies, as well as investigating treatments for those disorders.  He serves on the GBS/CIDP Foundation International Global Medical Advisory Board as well as the Inflammatory Neuropathy Consortium (INC) board.  


Dr. Allen reports the following:
  • Honoraria, consultation fees, advisory board: Akcea therapeutics, Argenx SE, Alexion, CSL Behring, Grifols, Johnson & Johnson, Pfizer, Takeda

Recent Contributions to PracticeUpdate:

  1. Axonal Damage Determines Clinical Disability in CIDP